DOCSLIB.ORG

Modulation of Voltage-Gated Channel Currents by Harmaline and Harmane

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Modulation of Voltage-Gated Channel Currents by Harmaline and Harmane British Journal of Pharmacology (2005) 144, 52–58 & 2005 Nature Publishing Group All rights reserved 0007–1188/05 $30.00 www.nature.com/bjp Modulation of voltage-gated channel currents by harmaline and harmane 1Frank Splettstoesser, 2Udo Bonnet, 1Martin Wiemann, 1Dieter Bingmann & *,1Dietrich Bu¨ sselberg 1Institut fu¨ r Physiologie, Universita¨ tsklinikum Essen, Universita¨ t-Duisburg Essen, Hufelandstrasse 55, 45122 Essen, Germany and 2Klinik fu¨ r Psychiatrie und Psychotherapie, Universita¨ tsklinikum Essen, Universita¨ t Duisburg Essen, Hufelandstrasse 55, 45122 Essen, Germany 1 Harmala alkaloids are endogenous substances, which are involved in neurodegenerative disorders such as M. Parkinson, but some of them also have neuroprotective effects in the nervous system. 2 While several sites of action at the cellular level (e.g. benzodiazepine receptors, 5-HT and GABAA receptors) have been identified, there is no report on how harmala alkaloids interact with voltage- gated membrane channels. 3 The aim of this study was to investigate the effects of harmaline and harmane on voltage-activated calcium- (ICa(V)), sodium- (INa(V)) and potassium (IK(V))-channel currents, using the whole-cell patch- clamp method with cultured dorsal root ganglion neurones of 3-week-old rats. Currents were elicited by voltage steps from the holding potential to different command potentials. 4 Harmaline and harmane reduced ICa(V), INa(V) and IK(V) concentration-dependent (10–500 mM) over the voltage range tested. ICa(V) was reduced with an IC50 of 100.6 mM for harmaline and by a significantly lower concentration of 75.8 mM (Po0.001, t-test) for harmane. The Hill coefficient was close to 1. Threshold concentration was around 10 mM for both substances. 5 The steady state of inhibition of ICa(V) by harmaline or harmane was reached within several minutes. The action was not use dependent and at least partly reversible. 6 It was mainly due to a reduction in the sustained calcium channel current (ICa(L þ N)), while the transient voltage-gated calcium channel current (ICa(T)) was only partially affected. 7 We conclude that harmaline and harmane are modulators of ICa(V) in vitro. This might be related to their neuroprotective effects. British Journal of Pharmacology (2005) 144, 52–58. doi:10.1038/sj.bjp.0706024 Keywords: Voltage-gated calcium currents; voltage-gated sodium currents; voltage-gated potassium currents; harmane; harmaline; dorsal root ganglion neurones; rat Abbreviations: BMI, Biomedical Instruments; CNS, central nervous system; DRG, dorsal root ganglion; F-12, Hams F-12 medium; GABAA, g-aminobutyric acid a receptor subtype; GHB, g-hydroxybutyrate; harmaline, 1-methyl-b- carboline; harmane, 1-methyl-7-methoxy-3,4-dihydro-b-carboline; 5-HT, 5-hydroxytryptamin; 5-HT2A, 5-hydro- xytryptamin 2A receptor; 5-HT2C, 5-hydroxytryptamin 2C receptor; ICa(L þ N), sustained voltage-gated calcium channel current; ICa(T), transient voltage-gated calcium channel current; ICa(V), voltage-gated calcium channel current; IK(V), voltage-gated potassium channel current; INa(V), voltage-gated sodium channel current; IC50, inhibitory concentration reducing 50%; I–V curve, current–voltage relation curve; MAO, monoaminoxidase; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin; NHE, sodium–hydrogen exchange; PC-12, rat adrenal pheochromocytoma Introduction The b-carbolines 1-methyl-b-carboline (harmane), 1-methyl-7- heroin-dependent humans (Stohler et al., 1996), patients with methoxy-3,4-dihydro-b-carboline (harmaline) and 9H-pyri- essential tremor (Louis et al., 2002) or Parkinson’s disease do[3,4-b]indole (norharmane) are naturally present in the (Kuhn et al., 1996), they are assumed to have a crucial role in human food chain and supposed to occur endogenously in the pathophysiology of various disorders of the CNS. normal body constituents. They are found in the blood plasma, Speculations on the biological significance of b-carbolines heart, kidney, liver and also in brain tissue, where they have comprised cytotoxic as well as neuroprotective properties. On been proposed to be endogeneous ligands for benzodiazepine the one hand, b-carbolines have been postulated to act as and imidazoline receptors (Rommelspacher et al., 1980; May endogeneous neurotoxins because of their structural similarity to et al., 1994; Hudson et al., 1999). Since high plasma levels of 1-methyl-4-phenyl-1-1,2,3,6-tetrahydropyridine (MPTP) (Albores these compounds have been found in heavy smokers (Spijker- et al., 1990), a compound which induced a parkinsonian-like man et al., 2002), alcoholics (Rommelspacher et al., 1991), syndrome in animals (Przedborski & Jackson-Lewis, 1998). Furthermore, harmaline has been shown to have a cytotoxic effect on PC-12cells (Cobuzzi et al., 1994) and to cause *Author for correspondence; E-mail: [email protected] degeneration of Purkinje cells in rat cerebellum. The latter finding Advance online publication: 8 November 2004 may explain its tremor-evoking action (O’hearn & Molliver, 1993). F. Splettstoesser et al Harmala alkaloids modulate voltage-gated currents 53 On the other hand, and, more recently, b-carbolines have Spinal cord was removed and dorsal root ganglia (DRG) were been shown to protect neurones against the excitotoxic effects collected by fine forceps from both sides of the spinal column of dopamine and glutamate (Maher & Davis, 1996). Accord- and transferred into ice-cooled F-12medium (Sigma, Tauf- ingly, a protective role of b-carbolines in the pathophysiology kirchen, Germany). Spinal nerves were cut off under optical of Parkinson’s disease has been suggested. Increasing evidence control using fine scissors. Then, the ganglia were transferred also hints to a protective effect of elevated endogeneous into a mixture of 0.9 ml F12medium plus 0.1 ml collagenase b-carbolines on oxidative neuronal damage. For example, medium (2612.5 U mlÀ1, Sigma Type II) and digested in a b-carbolines were shown to depress the dopamine- or humidified atmosphere (5% CO2)at371C for 45–55 min. In 6-hydroxydopamine-induced brain mitochondrial and synap- the next step, the collagenase was removed by washing the tosomal dysfunctions, and also the loss of viability in PC-12 ganglia with F-12medium for at least three times. Trypsina- cells through a scavenging action on reactive oxygen species tion (2525 U trypsin per ml F-12 medium, Sigma Type IX) was and maintenance of reduced thiols (Kim et al., 2001). carried out for another 2–3 min under the same conditions. Apart from actions on benzodiazepine and imidazoline After adding F-12medium (final volume 0.7 ml), the DRG receptors, other effects of b-carbolines have been identified at were titurated with a fire-polished Pasteur pipette (tip diameter the cellular level. These include an activation of 5-HT2A and 150 mM) until the ganglion capsules were opened, and the 5-HT2C receptors, a potent inhibition of synaptosomal g- neurones were released from the ganglia. A portion of 50 mlof hydroxybutyrate (GHB) re-uptake (McCormick & Tunnicliff, the resulting suspension was placed in the middle of small petri 1998), and an impairment of monoamine oxidase enzymes dishes (3 cm; Falcon ‘Easy Grip’) and incubated for 2–4 h, (MAO) and of sodium–hydrogen exchange (NHE) (Glennon allowing cells to adhere. Thereafter, 1 ml F-12(with horse et al., 2000; Anderson et al., 2003). serum) was added to each petri dish. Cultures were used for It appears surprising that, despite these manifold effects of electrophysiological recordings within the next 2days. harmale alkaloids on various targets, little information is available about their action on neuronal sodium, potassium Recording techniques and isolation of the different and calcium channel currents and calcium homeostasis (Shi channel currents et al., 2001). Especially calcium – entering through membrane channels – acts as a major second messenger, whose intracellular With the whole-cell patch-clamp technique, membrane cur- concentration is tightly regulated. De-regulation results in rents of DRG neurones were recorded using a HEKA EPC 9 reduced functionality of neurones, and a permanently increased amplifier and EPC screen software (HEKA). Microelectrodes calcium concentration within the cell could also result in were pulled from borosilicate glass with filament (o.d.: 1.5 mm malfunction and even cell death. Therefore, it might be possible and i.d.: 0.86 mm; Biomedical Instruments (BMI)) with a that the opposing effects of harmala alkaloids described above Sutter electrode puller (model P-87). Electrodes were fire may involve Ca2 þ -homeostasis disturbances. In neurones, i polished with a Narashige micro forge (MF-830) to a final calcium enters the cell through different types of voltage-gated resistance of 3–4 MO and filled with the adequate internal channels. The three main types of voltage-gated calcium solution (see Table 1; all chemicals for these solutions were channels which have originally been described and studied in obtained from Sigma-Aldrich, Taufkirchen, Germany). Special dorsal root ganglion (DRG) neurones are L-, N- and T-type bath solutions were prepared to isolate the different types of channels (Fox et al., 1987). They differ with respect to their voltage-activated channel currents (see Table 1). After a giga- voltage dependency and activation and inactivation properties ohm seal had been obtained and a stable access to the neurones (for details, see Hille, 1992). Most important for Ca2 þ home- i had been established, membrane potential was routinely ostasis are the noninactivating L-type channels, whose activa- clamped at À80 mV. Voltage-activated channel currents were tion starts at a membrane potential of around À30 mV, and elicited by depolarising command pulses to 0 mV for 120 ms transient T-type channels, which are fast inactivating and open (80 ms when measuring current–voltage (I–V) relations) for upon ‘small’ depolarisations (in the range of À50 to À10 mV). In I , 15 ms for I and 200 ms for I . Data were sampled this study, we investigated the effects of harmane and harmaline Ca(V) Na(V) K(V) at 10 kHz and stored on hard disc.
Load more

Recommended publications
  • National Center for Toxicological Research
    National Center for Toxicological Research Annual Report Research Accomplishments and Plans FY 2015 – FY 2016 Page 0 of 193 Table of Contents Preface – William Slikker, Jr., Ph.D. ................................................................................... 3 NCTR Vision ......................................................................................................................... 7 NCTR Mission ...................................................................................................................... 7 NCTR Strategic Plan ............................................................................................................ 7 NCTR Organizational Structure .......................................................................................... 8 NCTR Location and Facilities .............................................................................................. 9 NCTR Advances Research Through Outreach and Collaboration ................................... 10 NCTR Global Outreach and Training Activities ............................................................... 12 Global Summit on Regulatory Science .................................................................................................12 Training Activities .................................................................................................................................14 NCTR Scientists – Leaders in the Research Community .................................................. 15 Science Advisory Board ...................................................................................................
    [Show full text]
  • Long-Lasting Analgesic Effect of the Psychedelic Drug Changa: a Case Report
    CASE REPORT Journal of Psychedelic Studies 3(1), pp. 7–13 (2019) DOI: 10.1556/2054.2019.001 First published online February 12, 2019 Long-lasting analgesic effect of the psychedelic drug changa: A case report GENÍS ONA1* and SEBASTIÁN TRONCOSO2 1Department of Anthropology, Philosophy and Social Work, Universitat Rovira i Virgili, Tarragona, Spain 2Independent Researcher (Received: August 23, 2018; accepted: January 8, 2019) Background and aims: Pain is the most prevalent symptom of a health condition, and it is inappropriately treated in many cases. Here, we present a case report in which we observe a long-lasting analgesic effect produced by changa,a psychedelic drug that contains the psychoactive N,N-dimethyltryptamine and ground seeds of Peganum harmala, which are rich in β-carbolines. Methods: We describe the case and offer a brief review of supportive findings. Results: A long-lasting analgesic effect after the use of changa was reported. Possible analgesic mechanisms are discussed. We suggest that both pharmacological and non-pharmacological factors could be involved. Conclusion: These findings offer preliminary evidence of the analgesic effect of changa, but due to its complex pharmacological actions, involving many neurotransmitter systems, further research is needed in order to establish the specific mechanisms at work. Keywords: analgesic, pain, psychedelic, psychoactive, DMT, β-carboline alkaloids INTRODUCTION effects of ayahuasca usually last between 3 and 5 hr (McKenna & Riba, 2015), but the effects of smoked changa – The treatment of pain is one of the most significant chal- last about 15 30 min (Ott, 1994). lenges in the history of medicine. At present, there are still many challenges that hamper pain’s appropriate treatment, as recently stated by American Pain Society (Gereau et al., CASE DESCRIPTION 2014).
    [Show full text]
  • TAAR1 Activation Modulates Monoaminergic Neurotransmission, Preventing Hyperdopaminergic and Hypoglutamatergic Activity
    TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Florent G. Revela, Jean-Luc Moreaua, Raul R. Gainetdinovb, Amyaouch Bradaiac, Tatyana D. Sotnikovab, Roland Morya, Sean Durkina, Katrin Groebke Zbindend, Roger Norcrossd, Claas A. Meyere, Veit Metzlera, Sylvie Chaboza, Laurence Ozmena, Gerhard Trubea, Bruno Pouzeta, Bernhard Bettlerf, Marc G. Carong, Joseph G. Wettsteina, and Marius C. Hoenera,1 aNeuroscience Research, dDiscovery Chemistry, and eDiscovery Technologies, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; bDepartment of Neuroscience and Brain Technologies, Italian Institute of Technology, 16163 Genoa, Italy; cNeuroservice, Domaine de Saint-Hilaire, 13593 Aix-en-Provence, France; fDepartment of Biomedicine, Institute of Physiology, Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland; and gDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710 Edited by Richard D. Palmiter, University of Washington, Seattle, WA, and approved March 31, 2011 (received for review February 24, 2011) The trace amine-associated receptor 1 (TAAR1), activated by en- sitive to the locomotor-stimulating effect of d-amphetamine dogenous metabolites of amino acids like the trace amines and show elevated striatal release of dopamine (DA), noradren- p-tyramine and β-phenylethylamine, has proven to be an impor- aline (NA), and serotonin [5-hydroxytryptamine (5-HT)] after a d-amphetamine challenge (10, 12). Furthermore, the spontaneous tant modulator of the dopaminergic system and is considered −/− firing rate of the VTA DA neurons is augmented in Taar1 mice, a promising target for the treatment of neuropsychiatric disorders. fi To decipher the brain functions of TAAR1, a selective TAAR1 ago- and only in WT mice does pTyr decrease this ring rate (10).
    [Show full text]
  • Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion and Pharmacokinetics
    TESI DOCTORAL HUMAN PHARMACOLOGY OF AYAHUASCA JORDI RIBA Barcelona, 2003 Director de la Tesi: DR. MANEL JOSEP BARBANOJ RODRÍGUEZ A la Núria, el Marc i l’Emma. No pasaremos en silencio una de las cosas que á nuestro modo de ver llamará la atención... toman un bejuco llamado Ayahuasca (bejuco de muerto ó almas) del cual hacen un lijero cocimiento...esta bebida es narcótica, como debe suponerse, i á pocos momentos empieza a producir los mas raros fenómenos...Yo, por mí, sé decir que cuando he tomado el Ayahuasca he sentido rodeos de cabeza, luego un viaje aéreo en el que recuerdo percibia las prespectivas mas deliciosas, grandes ciudades, elevadas torres, hermosos parques i otros objetos bellísimos; luego me figuraba abandonado en un bosque i acometido de algunas fieras, de las que me defendia; en seguida tenia sensación fuerte de sueño del cual recordaba con dolor i pesadez de cabeza, i algunas veces mal estar general. Manuel Villavicencio Geografía de la República del Ecuador (1858) Das, was den Indianer den “Aya-huasca-Trank” lieben macht, sind, abgesehen von den Traumgesichten, die auf sein persönliches Glück Bezug habenden Bilder, die sein inneres Auge während des narkotischen Zustandes schaut. Louis Lewin Phantastica (1927) Agraïments La present tesi doctoral constitueix la fase final d’una idea nascuda ara fa gairebé nou anys. El fet que aquest treball sobre la farmacologia humana de l’ayahuasca hagi estat una realitat es deu fonamentalment al suport constant del seu director, el Manel Barbanoj. Voldria expressar-li la meva gratitud pel seu recolzament entusiàstic d’aquest projecte, molt allunyat, per la natura del fàrmac objecte d’estudi, dels que fins al moment s’havien dut a terme a l’Àrea d’Investigació Farmacològica de l’Hospital de Sant Pau.
    [Show full text]
  • (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
    pharmaceuticals Review Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact Andreia Machado Brito-da-Costa 1 , Diana Dias-da-Silva 1,2,* , Nelson G. M. Gomes 1,3 , Ricardo Jorge Dinis-Oliveira 1,2,4,* and Áurea Madureira-Carvalho 1,3 1 Department of Sciences, IINFACTS-Institute of Research and Advanced Training in Health Sciences and Technologies, University Institute of Health Sciences (IUCS), CESPU, CRL, 4585-116 Gandra, Portugal; [email protected] (A.M.B.-d.-C.); ngomes@ff.up.pt (N.G.M.G.); [email protected] (Á.M.-C.) 2 UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 3 LAQV-REQUIMTE, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal 4 Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal * Correspondence: [email protected] (D.D.-d.-S.); [email protected] (R.J.D.-O.); Tel.: +351-224-157-216 (R.J.D.-O.) Received: 21 September 2020; Accepted: 20 October 2020; Published: 23 October 2020 Abstract: Ayahuasca is a hallucinogenic botanical beverage originally used by indigenous Amazonian tribes in religious ceremonies and therapeutic practices. While ethnobotanical surveys still indicate its spiritual and medicinal uses, consumption of ayahuasca has been progressively related with a recreational purpose, particularly in Western societies. The ayahuasca aqueous concoction is typically prepared from the leaves of the N,N-dimethyltryptamine (DMT)-containing Psychotria viridis, and the stem and bark of Banisteriopsis caapi, the plant source of harmala alkaloids.
    [Show full text]
  • 'Gating' Residues Ile199 and Tyr326 in Human Monoamine Oxidase B
    The ‘gating’ residues Ile199 and Tyr326 in human monoamine oxidase B function in substrate and inhibitor recognition Erika M. Milczek1,*, Claudia Binda2, Stefano Rovida2, Andrea Mattevi2 and Dale E. Edmondson1 1 Departments of Chemistry and Biochemistry, Emory University, Atlanta, Georgia, USA 2 Department of Genetics and Microbiology, University of Pavia, Italy Keywords The major structural difference between human monoamine oxidases A dipartite to monopartite cavity conversion; (MAO A) and B (MAO B) is that MAO A has a monopartite substrate inhibitor specificity; monoamine oxidase B; cavity of 550 A˚3 volume and MAO B contains a dipartite cavity struc- mutations of gating residues; structure of ture with volumes of 290 A˚3 (entrance cavity) and 400 A˚3 (substrate methylene blue complex cavity). Ile199 and Tyr326 side chains separate these two cavities in MAO Correspondence B. To probe the function of these gating residues, Ile199Ala and Ile199Ala- D. E. Edmondson, Department of Tyr326Ala mutant forms of MAO B were investigated. Structural data on Biochemistry, Emory University, 1510 the Ile199Ala MAO B mutant show no alterations in active site geometries Clifton Road, Atlanta, GA 30322, USA compared with wild-type enzyme while the Ile199Ala-Tyr326Ala MAO B Fax: +1 404 727 2738 mutant exhibits alterations in residues 100–103 which are part of the loop Tel: +1 404 727 5972 gating the entrance to the active site. Both mutant enzymes exhibit catalytic E-mail: [email protected] properties with increased amine KM but unaltered kcat values. The altered *Present address KM values on mutation are attributed to the influence of the cavity struc- Department of Chemistry, Princeton ture in the binding and subsequent deprotonation of the amine substrate.
    [Show full text]
  • PAPER Monoamine Oxidase Inhibition Is Unlikely to Be Relevant To
    International Journal of Obesity (2001) 25, 1454–1458 ß 2001 Nature Publishing Group All rights reserved 0307–0565/01 $15.00 www.nature.com/ijo PAPER Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine: a comparison with their abilities to evoke monoamine release{ IC Kilpatrick1*, M Traut2 and DJ Heal1 1Knoll Limited Research and Development, Nottingham, UK; and 2Knoll GmbH, 50 Knollstrasse, D-67061, Ludwigshafen, Germany OBJECTIVE AND DESIGN: It has been proposed that the anti-obesity agent, phentermine, may act in part via inhibition of monoamine oxidase (MAO). The ability of phentermine to inhibit both MAOA and MAOB in vitro has been examined along with that of the fenfluramine isomers, a range of selective serotonin reuptake inhibitors and sibutramine and its active metabolites. RESULTS: In rat brain, harmaline and lazabemide showed potent and selective inhibition of MAOA and MAOB, their respective target enzymes, with IC50 values of 2.3 and 18 nM. In contrast, all other drugs examined were only weak inhibitors of MAOA and MAOB with IC50 values for each enzyme in the moderate to high micromolar range. For MAOA, the IC50 for phentermine was estimated to be 143 mM, that for S( þ )-fenfluramine, 265 mM and that for sertraline, 31 mM. For MAOB, example IC50s were as follows: phentermine (285 mM), S( þ )-fenfluramine (800 mM) and paroxetine (16 mM). Sibutramine was unable to inhibit either enzyme, even at its limit of solubility. CONCLUSION: We therefore suggest that MAO inhibition is unlikely to play a role in the pharmacodynamic properties of any of the tested drugs, including phentermine.
    [Show full text]
  • Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
    Supplemental Material can be found at: /content/suppl/2020/12/18/73.1.202.DC1.html 1521-0081/73/1/202–277$35.00 https://doi.org/10.1124/pharmrev.120.000056 PHARMACOLOGICAL REVIEWS Pharmacol Rev 73:202–277, January 2021 Copyright © 2020 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: MICHAEL NADER Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss Antonio Inserra, Danilo De Gregorio, and Gabriella Gobbi Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, Quebec, Canada Abstract ...................................................................................205 Significance Statement. ..................................................................205 I. Introduction . ..............................................................................205 A. Review Outline ........................................................................205 B. Psychiatric Disorders and the Need for Novel Pharmacotherapies .......................206 C. Psychedelic Compounds as Novel Therapeutics in Psychiatry: Overview and Comparison with Current Available Treatments . .....................................206 D. Classical or Serotonergic Psychedelics versus Nonclassical Psychedelics: Definition ......208 Downloaded from E. Dissociative Anesthetics................................................................209 F. Empathogens-Entactogens . ............................................................209
    [Show full text]
  • Chemical Composition of Traditional and Analog Ayahuasca
    Journal of Psychoactive Drugs ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/ujpd20 Chemical Composition of Traditional and Analog Ayahuasca Helle Kaasik , Rita C. Z. Souza , Flávia S. Zandonadi , Luís Fernando Tófoli & Alessandra Sussulini To cite this article: Helle Kaasik , Rita C. Z. Souza , Flávia S. Zandonadi , Luís Fernando Tófoli & Alessandra Sussulini (2020): Chemical Composition of Traditional and Analog Ayahuasca, Journal of Psychoactive Drugs, DOI: 10.1080/02791072.2020.1815911 To link to this article: https://doi.org/10.1080/02791072.2020.1815911 View supplementary material Published online: 08 Sep 2020. Submit your article to this journal View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ujpd20 JOURNAL OF PSYCHOACTIVE DRUGS https://doi.org/10.1080/02791072.2020.1815911 Chemical Composition of Traditional and Analog Ayahuasca Helle Kaasik a, Rita C. Z. Souzab, Flávia S. Zandonadib, Luís Fernando Tófoli c, and Alessandra Sussulinib aSchool of Theology and Religious Studies; and Institute of Physics, University of Tartu, Tartu, Estonia; bLaboratory of Bioanalytics and Integrated Omics (LaBIOmics), Institute of Chemistry, University of Campinas (UNICAMP), Campinas, SP, Brazil; cInterdisciplinary Cooperation for Ayahuasca Research and Outreach (ICARO), School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil ABSTRACT ARTICLE HISTORY Traditional ayahuasca can be defined as a brew made from Amazonian vine Banisteriopsis caapi and Received 17 April 2020 Amazonian admixture plants. Ayahuasca is used by indigenous groups in Amazonia, as a sacrament Accepted 6 July 2020 in syncretic Brazilian religions, and in healing and spiritual ceremonies internationally.
    [Show full text]
  • 5/1 (2005) 41 - 4541
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by idUS. Depósito de Investigación Universidad de Sevilla Vol. 5/1 (2005) 41 - 4541 JOURNAL OF NATURAL REMEDIES Cytotoxic activity of methanolic extract and two alkaloids extracted from seeds of Peganum harmala L. Hicham Berrougui1,2*, Miguel López-Lázaro1, Carmen Martin-Cordero1, Mohamed Mamouchi2, Abdelkader Ettaib2, Maria Dolores Herrera1. 1. Department of Pharmacology School of Pharmacy. Séville, Spain. 2. School of Medicine and Pharmacy, UFR (Natural Substances), Rabat, Morocco. Abstract Objective: To study the cytotoxic activity of P. harmala. Materials and method: The alkaloids harmine and harmaline have been isolated from a methanolic extract from the seeds of P. harmala L. and have been characterized by spectroscopic-Mass and NMR methods. The cytotoxicity of the methanolic extract and both alkaloids has been investigated in the three human cancer cell lines UACC-62 (melanoma), TK- 10 (renal) and MCF-7 (breast) and then compared to the positive control effect of the etoposide. Results and conclusion: The methanolic extract and both alkaloids have inhibited the growth of these three cancer cell-lines and we have discussed possible mechanisms involved in their cytotoxicity. Keywords: Peganum harmala, harmine, harmaline, cytotoxicity, TK-10, MCF-7, UACC-62. 1. Introduction Peganum harmala L. (Zygophyllaceae), the so- convulsive or anticonvulsive actions and called harmal, grows spontaneously in binding to various receptors including 5-HT uncultivated and steppes areas in semiarid and receptors and the benzodiazepine binding site pre-deserted regions in south Spain and South- of GABAA receptors [10]. In addition, these East Morocco [1].
    [Show full text]
  • Metabolic Pathways of the Psychotropic-Carboline Alkaloids, Harmaline and Harmine, by Liquid Chromatography/Mass Spectrometry and NMR Spectroscopy
    Food Chemistry 134 (2012) 1096–1105 Contents lists available at SciVerse ScienceDirect Food Chemistry journal homepage: www.elsevier.com/locate/foodchem Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy Ting Zhao a, Shan-Song Zheng a, Bin-Feng Zhang a,b,c, Yuan-Yuan Li a, S.W. Annie Bligh d, ⇑ ⇑ Chang-Hong Wang a,b,c, , Zheng-Tao Wang a,b,c, a Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201210, China b The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, 1200 Cailun Road, Shanghai 201210, China c Shanghai R&D Center for Standardization of Chinese Medicines, 199 Guoshoujing Road, Shanghai 201210, China d Institute for Health Research and Policy, London Metropolitan University, 166-220 Holloway Road, London N7 8DB, UK article info abstract Article history: The b-carboline alkaloids, harmaline and harmine, are present in hallucinogenic plants Ayahuasca and Received 3 June 2011 Peganum harmala, and in a variety of foods. In order to establish the metabolic pathway and bioactivities Received in revised form 25 January 2012 of endogenous and xenobiotic bioactive b-carbolines, high-performance liquid chromatography, coupled Accepted 6 March 2012 with mass spectrometry, was used to identify these metabolites in human liver microsomes (HLMs) Available online 16 March 2012 in vitro and in rat urine and bile samples after oral administration of the alkaloids. Three metabolites of harmaline and two of harmine were found in the HLMs.
    [Show full text]
  • Hallucinogens: an Update
    National Institute on Drug Abuse RESEARCH MONOGRAPH SERIES Hallucinogens: An Update 146 U.S. Department of Health and Human Services • Public Health Service • National Institutes of Health Hallucinogens: An Update Editors: Geraline C. Lin, Ph.D. National Institute on Drug Abuse Richard A. Glennon, Ph.D. Virginia Commonwealth University NIDA Research Monograph 146 1994 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 ACKNOWLEDGEMENT This monograph is based on the papers from a technical review on “Hallucinogens: An Update” held on July 13-14, 1992. The review meeting was sponsored by the National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other material in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors. Citation of the source is appreciated. Opinions expressed in this volume are those of the authors and do not necessarily reflect the opinions or official policy of the National Institute on Drug Abuse or any other part of the U.S. Department of Health and Human Services. The U.S. Government does not endorse or favor any specific commercial product or company.
    [Show full text]